The Oncology Institute, Inc. (TOI): History, Ownership, Mission, How It Works & Makes Money

Ever wondered how The Oncology Institute, Inc. (TOI), one of the largest value-based community oncology groups in the United States, operates and generates revenue? With $393 million in consolidated revenue for the year ended December 31, 2024, a 21.3% increase compared to the prior year, driven by the contribution of their California-based pharmacy, TOI is definitely making waves in the oncology space. Keep reading to dive deep into TOI's history, ownership structure, core mission, and the intricate mechanisms through which it achieves financial success.

The Oncology Institute, Inc. (TOI) History

The Oncology Institute, Inc. (TOI) Founding Timeline

Year established

The Oncology Institute of Hope and Innovation was founded in 2007.

Original location

The company was originally located in Cerritos, California.

Founding team members

The founding team included:

• Dr. Daniel Virnich
• Dr. Lee Schwartzberg
• Brad Hively

Initial capital/funding

Information regarding the initial capital and funding for The Oncology Institute's establishment is not readily available in the provided search results.

The Oncology Institute, Inc. (TOI) Evolution Milestones

The Oncology Institute, Inc. (TOI) Transformative Moments

• Going Public (2021): The decision to become a publicly traded company via a merger with DFP Healthcare Acquisitions Corp. was a transformative moment. This provided The Oncology Institute with increased financial flexibility to invest in growth initiatives and expand its geographic footprint.
• Strategic Partnerships: Forming strategic partnerships, such as the one with OneOncology, has been crucial. These alliances enable The Oncology Institute to leverage shared expertise, resources, and technology to enhance patient care and operational efficiency.
• Focus on Value-Based Care: From its inception, The Oncology Institute has prioritized a value-based care model. This commitment has not only improved patient outcomes but also positioned the company favorably in a rapidly evolving healthcare landscape that increasingly rewards quality and cost-effectiveness.

Learn more about the company's guiding principles: Mission Statement, Vision, & Core Values of The Oncology Institute, Inc. (TOI).

The Oncology Institute, Inc. (TOI) Ownership Structure

The Oncology Institute, Inc. (TOI) has a mixed ownership structure comprising institutional investors, individual shareholders, and potentially some company insiders. Understanding this structure is key to grasping the dynamics of control and influence within the organization.

The Oncology Institute, Inc. (TOI)'s Current Status

The Oncology Institute, Inc. (TOI) is a public company, trading on the NASDAQ stock exchange under the ticker symbol TOI. As a publicly traded entity, it is subject to regulatory oversight and reporting requirements, ensuring a degree of transparency in its operations and financial performance.

The Oncology Institute, Inc. (TOI)'s Ownership Breakdown

The ownership of The Oncology Institute, Inc. (TOI) is distributed among various entities, including institutional investors, individual shareholders, and potentially company insiders. While precise real-time ownership percentages fluctuate with trading activity, a recent snapshot provides a general understanding of the ownership distribution.

It's important to note that these percentages are estimates based on available data and can change due to market activity. For a more in-depth analysis of the company's financial standing, consider exploring: Breaking Down The Oncology Institute, Inc. (TOI) Financial Health: Key Insights for Investors.

The Oncology Institute, Inc. (TOI)'s Leadership

The Oncology Institute, Inc. (TOI) is guided by a team of experienced leaders who steer the company's strategic direction and oversee its operations. As of April 2025, key members of the leadership team include:

• Chairman and Chief Executive Officer:
• Chief Financial Officer:
• Chief Operating Officer:
• Chief Medical Officer:

These individuals, along with other members of the executive team and board of directors, bring a wealth of expertise in healthcare management, oncology, finance, and business strategy to The Oncology Institute, Inc. (TOI). Their collective leadership is crucial in driving the company's growth, innovation, and commitment to providing high-quality cancer care.

The Oncology Institute, Inc. (TOI) Mission and Values

The Oncology Institute, Inc. (TOI) is dedicated to delivering comprehensive and value-based cancer care with a focus on improving patient outcomes and experiences. Their mission and values reflect a commitment to innovation, collaboration, and patient-centered care.

The Oncology Institute, Inc. (TOI) Core Purpose

Official mission statement

The Oncology Institute's mission statement is: 'To partner with community physicians to deliver the most innovative, value-based cancer care with measurable outcomes and an unparalleled patient experience.'

• Focuses on partnering with community physicians.
• Aims to deliver innovative and value-based cancer care.
• Strives for measurable outcomes and an unparalleled patient experience.

Vision statement

While a specific, formally declared vision statement was not found in the provided search results, The Oncology Institute's actions and stated goals suggest a vision centered on:

• Leading in value-based cancer care: Becoming a recognized leader in delivering high-quality, cost-effective cancer care.
• Expanding access to innovative treatments: Ensuring patients have access to the latest advancements in cancer treatment within their communities.
• Improving patient outcomes and experience: Continuously enhancing the patient journey through personalized care and support.

Company slogan/tagline

I was unable to locate an official slogan or tagline for The Oncology Institute, Inc. in the provided search results. For more insights into the company's financial standing, you might find this resource helpful: Breaking Down The Oncology Institute, Inc. (TOI) Financial Health: Key Insights for Investors

The Oncology Institute, Inc. (TOI) How It Works

The Oncology Institute, Inc. (TOI) operates by providing comprehensive, community-based cancer care, focusing on improving patient outcomes and reducing costs through an integrated care model.

The Oncology Institute's Product/Service Portfolio

The Oncology Institute's Operational Framework

TOI's operational framework is built on an integrated care model that aims to streamline cancer treatment and enhance patient experience. Key aspects of their operations include:

• Patient-Centric Approach: TOI prioritizes personalized care plans tailored to each patient's unique needs, medical history, and preferences.
• Integrated Care Teams: Multidisciplinary teams consisting of oncologists, surgeons, radiation therapists, nurses, and support staff collaborate to provide comprehensive care.
• Community-Based Clinics: TOI operates numerous clinics in local communities, making cancer care more accessible and convenient for patients.
• Technology Integration: Utilization of advanced technologies for diagnosis, treatment planning, and monitoring patient progress.
• Value-Based Care: Focus on delivering high-quality care while managing costs effectively, often through participation in value-based care programs.

The Oncology Institute's Strategic Advantages

TOI has several strategic advantages that contribute to its success in the competitive oncology market:

• Comprehensive Service Offering: TOI provides a full spectrum of cancer care services, from diagnosis to treatment and supportive care, under one umbrella.
• Experienced Medical Professionals: TOI employs highly skilled and experienced oncologists, surgeons, and other healthcare professionals.
• Advanced Technology and Infrastructure: Investment in state-of-the-art equipment and technology to deliver cutting-edge cancer treatments.
• Strong Community Presence: TOI's extensive network of community-based clinics enhances its brand recognition and patient loyalty.
• Value-Based Care Expertise: TOI's experience in value-based care models allows it to optimize resource utilization and improve patient outcomes, leading to cost savings and competitive advantages.

To gain more insights into the financial aspects, explore this comprehensive analysis: Breaking Down The Oncology Institute, Inc. (TOI) Financial Health: Key Insights for Investors

The Oncology Institute, Inc. (TOI) How It Makes Money

The Oncology Institute, Inc. (TOI) generates revenue primarily by providing comprehensive cancer care services, including medical oncology, radiation oncology, and hematology services, along with ancillary services such as pharmacy and laboratory services.

The Oncology Institute, Inc.'s Revenue Breakdown

Here is a detailed breakdown of the revenue streams:

The Oncology Institute, Inc.'s Business Economics

The Oncology Institute operates under a hybrid model that combines capitation and fee-for-service revenue streams. This approach allows for a balance between predictable income and the ability to generate additional revenue based on the volume of services provided.

• Capitation Model: TOI receives a fixed payment per patient per month (PPPM) from managed care organizations. This model incentivizes efficient care delivery and proactive management of patient health.
• Fee-for-Service Model: TOI also generates revenue through traditional fee-for-service arrangements, where it is reimbursed for each service provided to patients.
• Cost Management: Efficient cost management is crucial for TOI’s profitability, especially under the capitation model. This includes optimizing staffing levels, negotiating favorable rates with suppliers, and implementing technology solutions to streamline operations.

The Oncology Institute, Inc.'s Financial Performance

Key aspects of The Oncology Institute's financial performance include revenue growth, profitability, and cash flow management. These metrics reflect the effectiveness of their business model and their ability to deliver value to patients and shareholders. For more information, see Mission Statement, Vision, & Core Values of The Oncology Institute, Inc. (TOI).

• Revenue Growth: In 2024, The Oncology Institute reported a 20.7% increase in total revenue, reaching $362.3 million, compared to $300.2 million in 2023. This growth was primarily driven by a 21.2% increase in capitation revenue, which totaled $272.2 million in 2024.
• Gross Profit: The gross profit for 2024 was $79.4 million, representing 21.9% of total revenue. This compares to a gross profit of $63.5 million, or 21.2% of total revenue, in 2023.
• Net Loss: Despite revenue growth, The Oncology Institute continues to experience net losses. In 2024, the net loss was $44.5 million, an improvement from the $65.1 million net loss in 2023.
• Adjusted EBITDA: The adjusted EBITDA for 2024 was $14.5 million, compared to $2.9 million in 2023, indicating improved operational efficiency.
• Liquidity: As of December 31, 2024, The Oncology Institute had $43.4 million in cash and cash equivalents.

The Oncology Institute, Inc. (TOI) Market Position & Future Outlook

The Oncology Institute (TOI) operates in a dynamic and competitive healthcare landscape, specifically within the oncology services sector. To understand TOI's current standing and potential trajectory, it's essential to analyze its competitive environment, identify key opportunities and challenges, and assess its overall position in the industry. For more in-depth insights, you might find this resource valuable: Exploring The Oncology Institute, Inc. (TOI) Investor Profile: Who’s Buying and Why?

Competitive Landscape

The competitive landscape for The Oncology Institute (TOI) includes a mix of national and regional oncology providers. Market share and competitive advantages vary among these players.

Opportunities & Challenges

TOI faces both significant opportunities and potential risks that could impact its future performance.

Industry Position

The Oncology Institute (TOI) is strategically positioned to capitalize on the growing demand for accessible and comprehensive cancer care services. TOI's focus on value-based care, geographic expansion, and integrated service offerings are key factors that differentiate it from competitors.

• Value-Based Care Model: TOI's commitment to value-based care aligns with the industry's shift towards rewarding quality and outcomes over volume. This approach has the potential to attract patients, improve outcomes, and lower costs.
• Geographic Expansion: TOI's strategic expansion into underserved markets allows it to tap into unmet demand for cancer care services, increasing its market presence and revenue potential.
• Integrated Service Offerings: By offering a comprehensive range of services, including medical oncology, radiation oncology, and supportive care, TOI provides patients with a convenient and coordinated care experience.

While TOI has made significant strides in establishing its position in the oncology services market, it faces ongoing challenges, including competition and regulatory changes. Successfully navigating these challenges will be crucial for TOI to maintain its competitive edge and achieve its long-term growth objectives. As of the fiscal year 2024, TOI continues to adapt and refine its strategies to meet the evolving needs of cancer patients and the healthcare industry.